Corruption of innate immunity by bacterial proteases

Journal of Innate Immunity

Volumn 1, Issue 2, 2009, Pages 70-87

  Potempa, Jan ^a,b   Pike, Robert N ^c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b University of Georgia   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Antimicrobial peptides; Complement; Inflammation; Phagocytosis; Protease; Proteolysis; Virulence

Indexed keywords

AERUGINOLYSIN; ALKALINE PROTEINASE; ANTHRAX TOXIN; AUREOLYSIN; BACTERIAL ENZYME; C5A PEPTIDASE; CHEMOKINE; CYTOKINE; DENTILISIN; ELASTASE; GINGIPAIN; IRON; MIRABILYSIN; MSP PEPTIDASE; OUTER MEMBRANE PROTEIN E; OUTER MEMBRANE PROTEIN T; PLASMINOGEN ACTIVATOR; PROTEIN SUFA; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; SERRALYSIN; STAPHOPAIN A; STAPHOPAIN B; STAPHYLOLYSIN; STREPTOPAIN; TREPOLISIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; PEPTIDE HYDROLASE;

BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CELL COMMUNICATION; COMPLEMENT SYSTEM; EPITHELIUM; FIBRINOLYSIS; HOST RESISTANCE; INNATE IMMUNITY; INTRACELLULAR SPACE; IRON TRANSPORT; KERATINOCYTE; LUNG SQUAMOUS CELL CARCINOMA; MUCOSA; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SKIN; ANIMAL; BACTERIA; CLASSIFICATION; ENZYMOLOGY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; PEPTIDE HYDROLASES; VIRULENCE;

EID: 61449163214     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000181144     Document Type: Review

References (123)

1. Esmon CT: Interactions between the innate immune and blood coagulation systems. Trends Immunol 2004; 25:536-542
2. Frick IM, Björck L, Herwald H: The dual role of the contact system in bacterial infectious disease. Thromb Haemost 2007; 98:497- 502.
3. Shpacovitch V, Feld M, Bunnett NW, Stein-hoff M: Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol 2007; 28:541-550.
4. Hollenberg MD, Oikonomopoulou K, Han-sen KK, Saifeddine M, Ramachandran R, Diamandis EP: Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer. Biol Chem 2008; 389: 6 4 3 - 651.
5. Ramsay AJ, Reid JC, Adams MN, Samara-tunga H, Dong Y, Clements JA, Hooper JD: Prostatic trypsin-like kallikrein-related pep-tidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PAR s). Biol Chem 2008; 389: 653- 668.
6. Hansen KK, Oikonomopoulou K, Baruch A, Ramachandran R, Beck P, Diamandis EP, Hollenberg MD: Proteinases as hormones: targets and mechanisms for proteolytic sig-naling. Biol Chem 2008; 389: 971-982.
7. Ulanova M, Gravelle S, Barnes R: The role of epithelial receptors in recognition of pulmo-nary pathogens. J Innate Immun 2009; 1:4- 17.
8. Bengtson SH, Sanden C., Morgelin M, Marx PF, Olin AI, Leed-Lundberg LMF, Meijers JCM, Herwald H: Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system. J Innate Immun 2009; 1:18-28.
9. Bengtson SH, Eddleston J, Mörgelin M, Zuraw BL, Herwald H: Regulation of kinin B(2) receptors by bradykinin in human lung cells. Biol Chem 2008, E-pub ahead of print.
10. Imamura T, Tanase S, Szmyd G, Kozik A, Travis J, Potempa J: Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus . J Exp Med 2005; 201: 1669-1676.
11. Imamura T, Potempa J, Pike RN, Travis J: Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis . Infect Im-mun 1995; 63:1999-2003.
12. Hu SW, Huang CH, Huang HC, Lai YY, Lin YY: Transvascular dissemination of Porphy-romonas gingivalis from a sequestered site is dependent upon activation of the kallikrein/ kinin pathway. J Periodontal Res 2006; 41: 200-207.
13. Sakata Y, Akaike T, Suga M, Ijiri S, Ando M, Maeda H: Bradykinin generation triggered by Pseudomonas proteases facilitates inva-sion of the systemic circulation by Pseudo-monas aeruginosa. Microbiol Immunol 1996; 40: 415-4 23.
14. Frick IM, Akesson P, Herwald H, Mörgelin M, Malmsten M, Nägler DK, Björck L: The contact system - a novel branch of innate immunity generating antibacterial peptides. EMBO J 2006; 25:5569-5578.
15. Bergmann S, Hammerschmidt S: Fibrinoly-sis and host response in bacterial infections. Thromb Haemost 2007; 98: 512 -52 0 .
16. Sanderson-Smith ML, Dinkla K, Cole JN, Cork AJ, Maamary PG, McArthur JD, Chhatwal GS, Walker MJ: M protein-mediated plasminogen binding is essential for the virulence of an invasive Streptococcus pyo-genes isolate. FASEB J 2008; 22: 2715-2722.
17. Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, Rozek LS, Wang X, Sjöbring U, Ginsburg D: Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004; 305: 1283-1286.
18. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL: Plasminogen is required for efficient dissemination of B. burg-dorferi in ticks and for enhancement of spi-rochetemia in mice. Cell 1997; 89: 1111 -111 9.
19. Parry MA, Fernandez-Catalan C, Bergner A, Huber R, Hopfner KP, Schlott B, Gührs KH, Bode W: The ternary microplasmin-staphy-lokinase-microplasmin complex is a pro-teinase-cofactor-substrate complex in action. Nat Struct Biol 1998; 5:917-923.
20. Ward PN, Abu-Median AB, Leigh JA: Structural consideration of the formation of the activation complex between the staphyloki-nase-like streptococcal plasminogen activator PadA and bovine plasminogen. J Mol Biol 2008; 381:734-747.
21. Hritonenko V, Stathopoulos C: Omptin proteins: an expanding family of outer membrane proteases in Gram-negative Entero-bacteriaceae . Mol Membr Biol 2007; 24: 395-406.
22. Kukkonen M, Suomalainen M, Kyllönen P, Lähteenmäki K, Lång H, Virkola R, Helan-der IM, Holst O, Korhonen TK: Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella ente-rica . Mol Microbiol 2004; 51: 215 -225.
23. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD: A surface protease and the invasive character of plague. Science 1992; 258:1004-1007.
24. Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ: Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of fleaborne plague. Proc Natl Acad Sci USA 2006; 103:5526-5530.
25. Lathem WW, Price PA, Miller VL, Goldman WE: A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 2007; 315:509-513.
26. Degen JL, Bugge TH, Goguen JD: Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 2007; 5(suppl 1):24-31.
27. Rytkönen A, Holden DW: Bacterial interference of ubiquitination and deubiquitination. Cell Host Microbe 2007; 1:13-22.
28. Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, Bliska JB, Mangel WF, Staskawicz B, Dixon JE: Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 2000; 290: 1594-1597.
29. Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, Wolf B, Dixit VM: Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kB activation. J Exp Med 2005; 202: 1327-1332.
30. Thiefes A, Wolf A, Doerrie A, Grassl GA, Matsumoto K, Autenrieth I, Bohn E, Sakurai H, Niedenthal R, Resch K, Kracht M: The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway. EMBO Rep 2006; 7:838-844.
31. Haase R, Richter K, Pfaffinger G, Courtois G, Ruckdeschel K: Yersinia outer protein P suppresses TGF-ß-activated kinase-1 activity to impair innate immune signaling in Yersinia enterocolitica-infected cells. J Immunol 2005; 175:8209-8217.
32. Sweet CR, Conlon J, Golenbock DT, Goguen J, Silverman N: YopJ targets TRAF proteins to inhibit TLR-mediated NF- kB, MAPK and IRF3 signal transduction. Cell Microbiol 2007; 9:2700-2715.
33. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, Orth K: Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 2006; 312: 1211-1214.
34. Trosky JE, Liverman AD, Orth K: Yersinia outer proteins: Yops. Cell Microbiol 2008; 10: 557-565.
35. Rytkönen A, Poh J, Garmendia J, Boyle C, Thompson A, Liu M, Freemont P, Hinton JC, Holden DW: SseL, a Salmonella deubiquitinase required for macrophage killing and virulence. Proc Natl Acad Sci USA 2007; 104: 3502-3507.
36. Le Negrate G, Faustin B, Welsh K, Loeffler M, Krajewska M, Hasegawa P, Mukherjee S, Orth K, Krajewski S, Godzik A, Guiney DG, Reed JC: Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kB, suppresses IkBα ubiquitination and modulates innate immune responses. J Immunol 2008; 180:5045-5056.
37. Misaghi S, Balsara ZR, Catic A, Spooner E, Ploegh HL, Starnbach MN: Chlamydia trachomatis - derived deubiquitinating enzymes in mammalian cells during infection. Mol Microbiol 2006; 61: 142-150.
38. Catic A, Misaghi S, Korbel GA, Ploegh HL: ElaD, a deubiquitinating protease expressed by E . coli. PLoS One 2007; 2:e381.
39. Chosed R, Tomchick DR, Brautigam CA, Mukherjee S, Negi VS, Machius M, Orth K: Structural analysis of Xanthomonas XopD provides insights into substrate specificity of ubiquitin-like protein proteases. J Biol Chem 2007; 282: 6773-6782.
40. Shao F, Merritt PM, Bao Z, Innes RW, Dixon JE: A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogen-esis. Cell 2002; 10 9: 575 -588 .
41. Park JM, Greten FR, Li ZW, Karin M: Mac-rophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 2002; 297: 2048-2051.
42. Kuo CF, Lin YS, Chuang WJ, Wu JJ, Tsao N: Degradation of complement 3 by streptococ-cal pyrogenic exotoxin B inhibits complement activation and neutrophil opsono-phagocy tosis. Infect Immun 20 08; 76 : 1163-1169.
43. Ter ao Y, Mor i Y, Yamaguchi M, Shimizu Y, Ooe K, Hamada S, Kawabata S: Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity. J Biol Chem 2008; 283:6253- 6260.
44. Tsao N, Tsai WH, Lin YS, Chuang WJ, Wang CH, Kuo CF: Streptococcal pyrogenic exo-toxin B cleaves properdin and inhibits complement-mediated opsonophagocytosis. Biochem Biophys Res Commun 2006; 339: 779-784.
45. Ji Y, McLandsborough L, Kondagunta A, Cleary PP: C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun 1996; 64: 503- 510.
46. Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM: Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis 2008; 198:125-133.
47. Ramu P, Tanskanen R, Holmberg M, Läh-teenmäki K, Korhonen TK, Meri S: The sur-face protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5. FEBS Lett 2007; 581: 17 16 -17 2 0 .
48. Park SY, Kim KM, Lee JH, Seo SJ, Lee IH: Extracellular gelatinase of Enterococcus fae-calis destroys a defense system in insect he-molymph and human serum. Infect Immun 2007; 75: 18 6 1-18 6 9.
49. Popadiak K, Potempa J, Riesbeck K, Blom AM: Biphasic effect of gingipains from Por-phyromonas gingivalis on the human complement system. J Immunol 2007; 17 8 : 7242- 7250.
50. Slaney JM, Gallagher A, Aduse-Opoku J, Pell K, Curtis MA: Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement. Infect Immun 2006; 74: 5352-5361.
51. Potempa M, Potempa J, Okroj M, Popadiak K, Eick S, Nguyen K-A, Riesbeck K, Blom AM: Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis. J Immunol 2008; 181:5537-5544.
52. Lathem WW, Bergsbaken T, Welch RA: Po-tentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7. J Exp Med 2004; 199:1077-1087.
53. Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ: Defensin participation in innate and adaptive immunity. Curr Pharm Des 2007; 13:3131-3139.
54. Eliasson M, Egesten A: Antibacterial chemo-kines - actors in both innate and adaptive immunity. Contrib Microbiol 2008; 15: 101- 117.
55. Nordahl EA, Rydengård V, Nyberg P, Nitsche DP, Mörgelin M, Malmsten M, Björck L, Schmidtchen A: Activation of the complement system generates antibacterial pep-tides. Proc Natl Acad Sci USA 2004; 101: 16879-16884.
56. Pasupuleti M, Walse B, Nordahl EA, Mörge-lin M, Malmsten M, Schmidtchen A: Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem 2007; 282:2520-2528.
57. Mak P: Hemocidins in a functional and structural context of human antimicrobial peptides. Front Biosci 2008; 13:6859-6871.
58. Nordahl EA, Rydengård V, Mörgelin M, Schmidtchen A: Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem 20 05; 28 0: 34832-34839.
59. Rydengård V, Olsson AK, Mörgelin M, Schmidtchen A: Histidine-rich glycoprotein exerts antibacterial activity. FEBS J 2007; 274:377-389.
60. Malmsten M, Davoudi M, Schmidtchen A: Bacterial killing by heparin-binding pep-tides from PRELP and thrombospondin. Matrix Biol 20 06; 25: 294 -30 0.
61. Malmsten M, Davoudi M, Walse B, Rydengård V, Pasupuleti M, Mörgelin M, Schmidtchen A: Antimicrobial peptides derived from growth factors. Growth Factors 2007; 25:60-70.
62. Radek K, Gallo R: Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol 20 07; 29: 27-43.
63. Nizet V: Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol 2006; 8:11-26.
64. Karlsson C, Andersson ML, Collin M, Schmidtchen A, Björck L, Frick IM: SufA - a novel subtilisin-like serine proteinase of Fi-negoldia magna . Microbiology 2007; 153: 4208-4218.
65. Schmidtchen A, Frick IM, Andersson E, Tapper H, Björck L: Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Micro-biol 2002; 46: 1 5 7-16 8 .
66. Schmidtchen A, Frick IM, Björck L: Derma-tan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol Microbiol 2001; 39:708-713.
67. Park PW, Pier GB, Preston MJ, Goldberger O, Fitzgerald ML, Bernfield M: Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J Biol Chem 2000; 275:3057-3064.
68. Belas R, Manos J, Suvanasuthi R: Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect Immun 2004; 72: 5159-5167.
69. Carlisle MD, Srikantha RN, Brogden KA: Degradation of α- and ß-defensins by culture supernatants of Porphyromonas gingi-valis strain 381. J Innate Immun 2009; 1:118-122.
70. Bachrach G, Altman H, Kolenbrander PE, Chalmers NI, Gabai-Gutner M, Mor A, Friedman M, Steinberg D: Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent. Antimicrob Agents Chemother 2008; 52: 638-642.
71. Taggart CC, Greene CM, Smith SG, Levine RL, McCray PB Jr, O'Neill S, McElvaney NG: Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. J Immunol 2003; 171:931-937.
72. Puklo M, Guentsch A, Hiemstra PS, Eick S, Potempa J: Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol 2008; 23:328-335.
73. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wójcik K, Puklo M, Lupa B, Suder P, Silber-ring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J: Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus -derived proteinases. Antimicrob Agents Chemother 2004; 48: 4673-4679.
74. Lai Y, Villaruz AE, Li M, Cha DJ, Sturdevant DE, Otto M: The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol Microbiol 2007; 63:497-506.
75. Jin T, Bokarewa M, Foster T, Mitchell J, Hig-gins J, Tarkowski A: Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 2004; 172: 1169-1176.
76. Braff MH, Jones AL, Skerrett SJ, Rubens CE: Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis. J Infect Dis 2007; 195: 1365-1372.
77. Vincents B, Onnerfjord P, Gruca M, Potempa J, Abrahamson M: Down-regulation of human extracellular cysteine protease inhibitors by the secreted staphylococcal cysteine proteases, staphopain A and B. Biol Chem 2007; 388:437-446.
78. Nyberg P, Rasmussen M, Björck L: α-2-Mac-roglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem 2004; 279:52820-52823.
79. Johansson L, Thulin P, Sendi P, Hertzén E, Linder A, Akesson P, Low DE, Agerberth B, Norrby-Teglund A: Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect Immun 2008; 76: 3399-3404.
80. Hwang BY, Varadarajan N, Li H, Rodriguez S, Iverson BL, Georgiou G: Substrate specificity of the Escherichia coli outer membrane protease OmpP. J Bacteriol 2007; 189:522-530.
81. Guina T, Yi EC, Wang H, Hackett M, Miller SI: A PhoP-regulated outer membrane protease of Salmonella enterica serovar Ty-phimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol 2000; 182: 4077-4086.
82. Bader MW, Navarre WW, Shiau W, Nikaido H, Frye JG, McClelland M, Fang FC, Miller SI: Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol Microbiol 2003; 50: 219-230.
83. Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, Mackie EJ, Pike RN: Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gin-gipain-R from Porphyromonas gingivalis. FEBS Lett 1998; 435: 45-48.
84. Lourbakos A, Potempa J, Travis J, DAndrea MR, Andrade-Gordon P, Santulli R, Mackie EJ, Pike RN: Arginine-specific protease from Porphyromonas gingivalis activates prote-ase-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 2001; 69: 5121-5130.
85. Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R, Potempa J, Pike RN: Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 2001; 97:3790-3797.
86. Holzhausen M, Spolidorio LC, Ellen RP, Jo-bin MC, Steinhoff M, Andrade-Gordon P, Vergnolle N: Protease-activated receptor-2 activation: a major role in the pathogenesis of Porphyromonas gingivalis infection. Am J Pathol 2006; 168:1189-1199.
87. Kida Y, Higashimoto Y, Inoue H, Shimizu T, Kuwano K: A novel secreted protease from Pseudomonas aeruginosa activates NF-kB through protease-activated receptors. Cell Microbiol 2008; 10: 1491-504.
88. Dulon S, Leduc D, Cottrell GS, D'Alayer J, Hansen KK, Bunnett NW, Hollenberg MD, Pidard D, Chignard M: Pseudomonas aeru-ginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am J Respir Cell Mol Biol 2005; 32:411-419.
89. Kida Y, Inoue H, Shimizu T, Kuwano K: Ser-ratia marcescens serralysin induces inflammatory responses through protease-activat-ed receptor 2. Infect Immun 2007; 75: 164 -174.
90. Kajikawa H, Yoshida N, Katad a K, Hirayama F, Handa O, Kokura S, Naito Y, Yoshikawa T: Helicobacter pylori activates gastric epithelial cells to produce interleukin-8 via prote-ase-activated receptor 2. Digestion 2007; 76: 248-255.
91. Sheets SM, Robles-Price AG, McKenzie RM, Casiano CA, Fletcher HM: Gingipain-dependent interactions with the host are important for survival of Porphyromonas gingivalis . Front Biosci 2008; 13: 3215- 3238.
92. Fitzpatrick R, Aprico A, Wijeyewickrema LC, Pagel CN, Wong D, Potempa J, Eleanor J. Mackie EJ, Pike RN: High molecular weight gingipains from Porphyromonas gingivalis induce cytokine responses from human macrophage-like cells via a non-proteolytic mechanism. J Innate Immun 2009; 1:109-117.
93. Wolf M, Albrecht S, Märki C: Proteolytic processing of chemokines: implications in physiological and pathological conditions. Int J Biochem Cell Biol 2008; 40: 118 5 - 1198.
94. Dean RA, Cox JH, Bellac CL, Doucet A, Starr AE, Overall CM: Macrophage-spe-cific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, 7, 8, and 13 antagonists: potential role of the macrophage in terminating PMN influx. Blood 2008; 112: 3455-3464.
95. Mikolajczyk-Pawlinska J, Travis J, Potem-pa J: Modulation of interleukin-8 activity by gingipains from Porphyromonas gingi-valis: implications for pathogenicity of periodontal disease. FEBS Lett 1998; 440: 282-286.
96. Leidal KG, Munson KL, Johnson MC, Denning GM: Metalloproteases from Pseudo-monas aeruginosa degrade human RAN-TES, MCP-1, and ENA-78. J Interferon Cytokine Res 2003; 23:307-318.
97. Edwards RJ, Taylor GW, Ferguson M, Murray S, Rendell N, Wrigley A, Bai Z, Boyle J, Finney SJ, Jones A, Russell HH, Turner C, Cohen J, Faulkner L, Sriskandan S: Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes . J Infect Dis 2005; 192: 783 -790.
98. Zinkernagel AS, Timmer AM, Pence MA, Locke JB, Buchanan JT, Turner CE, Misha-lian I, Sriskandan S, Hanski E, Nizet V: The IL-8 protease SpyCEP/ScpC of group A Streptococcus promotes resistance to neu-trophil killing. Cell Host Microbe 2008; 4: 170 -178.
99. Chiang-Ni C, Wang CH, Tsai PJ, Chuang WJ, Lin YS, Lin MT, Liu CC, Wu JJ: Strep-tococcal pyrogenic exotoxin B causes mitochondria damage to polymorphonuclear cells preventing phagocytosis of group A Streptococcus . Med Microbiol Immunol 2006; 195:55-63.
100. Söderberg JJ, von Pawel-Rammingen U: The streptococcal protease IdeS modulates bacterial IgGFc binding and generates 1/2Fc fragments with the ability to prime polymorphonuclear leucocytes. Mol Immunol 2008; 45:3347-3353.
101. Vincents B, Vindebro R, Abrahamson M, von Pawel-Rammingen U: The human protease inhibitor cystatin C is an activating cofactor for the streptococcal cysteine protease IdeS. Chem Biol 20 08; 15: 960-968.
102. Thulin P, Johansson L, Low DE, Gan BS, Kotb M, McGeer A, Norrby-Teglund A: Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med 2006; 3:e53.
103. Kubica M, Guzik K, Koziel J, Zarebski M, Richter W, Gajkowska B, Golda A, Maciag-Gudowska A, Brix K, Shaw L, Foster T, Po-tempa J: A potential new pathway for Staph-ylococcus aureus dissemination: the silent survival of S . aureus phagocytosed by human monocyte-derived macrophages. PLoS One 2008; 3:e14 0 9.
104. Tada H, Sugawara S, Nemoto E, Takahashi N , Imamura T, Potempa J ,Travis J, Shimau-chi H, Takada H: Proteolysis of CD14 on human gingival fibroblasts by arginine-specific cysteine proteinases from Porphy-romonas gingivalis leading to down-regulation of lipopolysaccharide-induced inter-leukin-8 production. Infect Immun 2002; 70: 330 4-3307.
105. Cichy J, Bals R, Potempa J, Mani A, Puré E: Proteinase-mediated release of epithelial cell-associated CD44: extracellular CD44 complexes with components of cellular matrices. J Biol Chem 2002; 277: 44440-44447.
106. Chen Y, Hayashida A, Bennett AE, Hol-lingshead SK, Pa rk PW: Streptococcus pneu-moniae sheds syndecan-1 ectodomains through ZmpC, a metalloproteinase virulence factor. J Biol Chem 2007; 282: 159 - 167.
107. Andrian E, Grenier D, Rouabhia M: Por-phyromonas gingivalis gingipains mediate the shedding of syndecan-1 from the surface of gingival epithelial cells. Oral Micro-biol Immunol 2006; 21:123-128.
108. Leduc D, Beaufort N, de Bentzmann S, Rousselle JC, Namane A, Chignard M, Pidard D: The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific en-doproteolysis. Infect Immun 2007; 75: 3848-3858.
109. Smagur J, Guzik K, Magiera L, Bzowska M, Gruca M, Thøgersen IB, Enghild JJ, Potem-pa J: A new pathway of staphylococcal pathogenesis: apoptosis-like death induced by staphopain B (SspB) in human peripheral blood neutrophils and monocytes. J Innate Immun 2009; 1:98-108.
110. Guzik K, Bzowska M, Smagur J, Krupa O, Sieprawska M, Travis J, Potempa J: A new insight into phagocytosis of apoptotic cells: proteolytic enzymes divert the recognition and clearance of polymorphonuclear leukocytes by macrophages. Cell Death Differ 2007; 14 : 17 1-18 2 .
111. Otto BR, van Dooren SJ, Dozois CM, Lui-rink J, Oudega B: Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis. Infect Immun 2002; 70: 5-10.
112. Smalley JW, Birss AJ, Szmigielski B, Potem-pa J: Mechanism of methaemoglobin breakdown by the lysine-specific gingipain of the periodontal pathogen Porphyromonas gin-givalis . Biol Chem 2008; 389: 1235-1238.
113. Smalley JW, Birss AJ, Szmigielski B, Potem-pa J: Sequential action of R- and K-specific gingipains of Porphyromonas gingivalis in the generation of the haem-containing pigment from oxyhaemoglobin. Arch Biochem Biophys 2007; 465: 44 - 49.
114. Oido-Mori M, Rezzonico R, Wang PL, Kowashi Y, Dayer JM, Baehni PC, Chizzo-lini C: Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact. Infect Im-mu n 20 01; 69: 4493-4501.
115. Chung WO, Hansen SR, Rao D, Dale BA: Protease-activated receptor signaling increases epithelial antimicrobial peptide expression. J Immunol. 2004; 173:5165-5170.
116. Tancharoen S, Sarker KP, Imamura T, Biswas KK, Matsushita K, Tatsuyama S, Travis J, Potempa J, Torii M, Maruyama I: Neuropeptide release from dental pulp cells by RgpB via proteinase-activated receptor-2 signaling. J Immunol 2005; 174:5796- 5804.
117. Inomata M, Into T, Ishihara Y, Nakashima M, Noguchi T, Matsushita K: Arginine-specific gingipain A from Porphyromonas gingivalis induces Weibel-Palade body exo-cytosis and enhanced activation of vascular endothelial cells through protease-activat-ed receptors. Microbes Infect 2007; 12-13: 1500 -150 6.
118. Yun LW, Decarlo AA, Hunter N: Blockade of protease-activated receptors on T cells correlates with altered proteolysis of CD27 by gingipains of Porphyromonas gingivalis. Clin Exp Immunol 2007; 150: 217-229.
119. Uehara A, Muramoto K, Imamura T, Na-kayama K, Potempa J, Travis J, Sugawara S, Takada H: Arginine-specific gingipains from Porphyromonas gingivalis st imulate production of hepatocyte growth factor (scatter factor) through protease-activated receptors in human gingival fibroblasts in culture. J Immunol 2005; 175:6076-6084.
120. Dommisch H, Chung WO, Rohani MG, Williams D, Rangarajan M, Curtis MA, Dale BA: Protease-activated receptor 2 mediates human beta-defensin 2 and CC che-mokine ligand 20 mRNA expression in response to proteases secreted by Porphy-romonas gingivalis . Infect Immun 2007; 75: 4326 - 4333.
121. Giacaman RA, Nobbs AH, Ross KF, Herz-berg MC: Porphyromonas gingivalis selectively up-regulates the HIV-1 coreceptor CCR5 in oral keratinocytes. J Immunol 2007; 179: 2542-2550.
122. Uehara A, Imamura T, Potempa J, Travis J, Takada H: Gingipains from Porphyromo-nas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell Microbiol 2008; 10:1181-1189.
123. Uehara A, Naito M, Imamura T, Potempa J, Travis J, Nakayama K, Takada H: Dual regulation of interleukin-8 production in human oral epithelial cells upon stimulation with gingipains from Porphyromonas gin-givalis . J Med Microbiol 2008; 57:500-507.